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Abstract
Background: Lipids are important for the cell and organism life since they are major components of membranes,
energy reserves and are also signal molecules. The main organs for the energy synthesis and storage are the liver
and adipose tissue, both in humans and in more distant species such as chicken. Long noncoding RNAs (lncRNAs)
are known to be involved in many biological processes including lipid metabolism.
Results: In this context, this paper provides the most exhaustive list of lncRNAs involved in lipid metabolism with
60 genes identified after an in-depth analysis of the bibliography, while all “review” type articles list a total of 27
genes. These 60 lncRNAs are mainly described in human or mice and only a few of them have a precise described
mode-of-action. Because these genes are still named in a non-standard way making such a study tedious, we
propose a standard name for this list according to the rules dictated by the HUGO consortium. Moreover, we
identified about 10% of lncRNAs which are conserved between mammals and chicken and 2% between mammals
and fishes. Finally, we demonstrated that two lncRNA were wrongly considered as lncRNAs in the literature since
they are 3′ extensions of the closest coding gene.
Conclusions: Such a lncRNAs catalogue can participate to the understanding of the lipid metabolism regulators; it
can be useful to better understand the genetic regulation of some human diseases (obesity, hepatic steatosis) or
traits of economic interest in livestock species (meat quality, carcass composition). We have no doubt that this first
set will be rapidly enriched in coming years.
Keywords: lncRNA, Lipid metabolism, Liver, Evolution, Synteny
Background
Lipids are found in all organisms and are essential for
life [1–3]. They contribute to cell membrane constitu-
tion, acting as signaling molecules and as an important
source of energy. In animal species, the deregulation of
lipid homeostasis processes is responsible for dyslipid-
emia and many diseases of major importance in human
health such as obesity, diabetes, non-alcoholic fatty liver
disease (NAFLD) or cardiovascular diseases. The major
site of lipid synthesis may differ from one species to an-
other. Lipogenesis from carbohydrates sources occurs
mainly in the liver in primates and rodents, and in
adipose tissue in carnivores and ungulates (pig, cow,
goat, dog) [1]. Note that for chicken [4–6] and many
fishes [7], the major site of de novo fatty acid synthesis
is the liver. The synthesis of cholesterol in mammals,
birds and fish is more ubiquitous but predominates in
the liver [5, 8–10]. The storage of fatty acids in triglycer-
ides is the main animal’s energy reserve, which is consti-
tuted during periods of energy excess and mobilized
during periods of energy deprivation. This storage
mainly occurs in adipose tissue within the adipocytes.
Energy homeostasis is regulated by hypothalamus which
regulates food intake and energy expenditure [11], and
involves many hormones and adipokines to organize the
crosstalk between organs. Lipid metabolism is a complex
process that involves a large variety of molecular
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pathways and different transcriptional regulators some
of which have been described so far.
Since the 2000s, with the advent of whole-genome se-
quencing technologies, most genes coding essentially for
proteins have gradually been identified. The databases
reference nearly 20,000 genes in human [12] [Human
GENCODE v.28–10 July 2018], 22,000 in mouse [13]
[Mouse GENCODE v.M17–10 July 2018] and pig
[Ensembl v.92–10 July 2018], 18,000 in chicken
[Ensembl v.92–10 July 2018]. Small RNAs, such as
miRNA that do not code for proteins, are also relatively
well annotated today (from 1705 to 5531). In contrast,
long noncoding RNA (lncRNA) are less described in the
genomes: they are strictly defined as RNAs of more than
200 nt with no ORF long enough to be translated into a
protein (< 150 nt) [14]. They have important roles since
they control the regulation of gene expression via a large
diversity of mechanisms as they can interact with DNA,
RNA or proteins [15, 16]. The number of lncRNAs with
a well-described functional role is now estimated at 1%
[17]. lncRNA genes appear to be as numerous as or even
more numerous than genes encoding proteins with 15,
779 and 12,533 lncRNA referenced via the GENCODE
projects [12–14] in human [Human GENCODE v.28]
and mouse [Mouse GENCODE v.M17], respectively.
Modeling of these gene entities structure is far from
complete. In human, specialized databases such as
NONCODE [18] or LNCipedia [19] announce even
higher numbers than those referenced in Ensembl and
NCBI databases. On the contrary, in less studied live-
stock species such as pig and chicken [Ensembl v.92], a
very small fraction of lncRNA is referenced (361 and
4643, respectively). So far, most lncRNA and their
underlying transcripts, are gene models predicted by bio-
informatics pipelines from RNAseq data and in the ma-
jority of species have rarely been experimentally
confirmed. The difficulty of lncRNA gene modeling and
identification is due to different causes: 1. an expression
10 to 100 times weaker than the protein coding genes
[14, 20, 21], which makes harder the identification of the
different transcripts exon-intron structures and therefore
of the gene locus; 2. the tissue-specificity of lncRNA ex-
pression [14, 20], requiring the use of many different tis-
sues to establish an exhaustive catalogue; 3. the criteria
used for lncRNA prediction that can be the presence of
an ORF, a blast against a protein database, the size of
transcripts and/or the composition in k-mers, depending
on the bioinformatics tool used; the main tools being
CPC [22, 23], CPAT [24], PhyloCSF [25], FEELnc [26]
and the Ulitsky’s team pipeline PLAR [27]. 4. Finally, a
last point concerns the low conservation of lncRNA se-
quences between species, especially for species that are
evolutionary distant [14, 20, 27–30]. All these drawbacks
make it difficult to find orthologous long noncoding
genes by sequence conservation analysis, as frequently
done for protein-coding genes.
The first review about lncRNAs involved in lipid me-
tabolism is very recent [31] (2016). Since then several
other reviews and articles were published but none of
them provided an exhaustive lipid-related lncRNA cata-
logue. The first objective of this study was to fill this gap
providing an exhaustive catalogue of lncRNAs involved
in lipid metabolism. An extensive analysis of the litera-
ture, generally focusing on human or mouse, allowed us
to draw up a catalogue of 60 lncRNA genes related to
lipid metabolism for which we report mechanisms of ac-
tion when it is described This led us to highlight some
spurious genes and therefore, to rename some lncRNAs
in accordance to the rules published by the HUGO Gene
Nomenclature Committee for long noncoding genes
[32]. Second, we analyzed the conservation of these 60
lncRNA in chicken, which last shared common ancestor
with mammal dates back to 300M years ago, with the
assumption that such a conservation would support an
important role of these genes in the metabolism of inter-
est. For this, an approach by synteny analysis was used,
which highlighted 5 lncRNAs preserved between hu-
man/mouse and chicken. Finally, we have more precisely
described their functional roles and analyzed their con-
servation between 8 species from mammals to zebrafish.
Results
60 lncRNA identified as involved in lipid metabolism by
expert curation of the literature
To our knowledge, the first catalogue of lncRNA poten-
tially involved in lipid metabolism was proposed by
Chen in 2016 [31] and included the 5 lncRNA, called
lncLSTR, HULC, APOA1-AS, lincRNA-DYNLRB2–2 and
SRA. The same year, Zhou et al. [33] published a
broader review of lncRNA genes potentially involved in
lipid and glucose metabolisms and related diseases (ath-
erosclerosis, type 2 diabetes, insulin resistance) in which
TRIBAL, ANRIL, lncLSTR, AT102202, APOA1-AS,
lincRNA-DYNLRB2–2, RP5-833A20.1 and CRNDE were
described as involved in lipid metabolism. Later in the
year, Smekalova et al. [34] published a list of lncRNA in-
volved in liver pathophysiology including two lncRNA
involved in lipid metabolism HULC and lincRNA-
DYNLRB2–2 and Ananthanarayanan [35] reports three
other lncRNAs involved in triglyceride, cholesterol and
bile acid homeostasis: lnc-HC, lncLSTR, APOA1-AS. In
2017, Zhao et al. [36] present a review on lncRNA in-
volved in liver metabolism and cholestatic liver disease
in which lncLSTR, Lnc18q22.2, SRA1, HULC, MALAT1,
lncHR1 were related to the lipid metabolism and lnc-
HC, APOA1-AS, H19, MEG3, lincRNA-DYNLRB2–2,
LeXis involved in cholestatic liver pathologies. More re-
cently, in 2018, Van Solingen et al. [17] present a review
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covering the 12 lncRNA previously described by Zhao
et al. enriched with RP5-833A20.1 renamed NFIA-AS1
and MeXis a new lncRNA discovered in early 2018 by
the team of Tontonoz [37]. Likewise recently, Zeng et al.
[38] added eight other lncRNAs: Gm16551, SPRY4-IT1,
APOA4-AS, LINK-A, RP1-13D10.2, E330013P06 (named
CARMN in databases), LOC100506036 (named CNNM3-
DT in databases) and SNHG14. All these reviews report
a total of 27 lncRNA involved in lipid metabolism. An
extensive literature analysis allowed us to add 33 new
lncRNAs, bringing the total to 60 lncRNAs. These extra
lncRNAs include one identified in 2015 not mentioned
in the aforementioned studies, it was the lncRNA
AT115872 described with the lncRNA AT102202 (more
largely cited in the literature). The first acts at distance
on the expression of ACAT2, that encodes a key enzyme
for the absorption of dietary cholesterol, while the sec-
ond acts locally on the HMGCR gene, which encodes a
key enzyme for cholesterol anabolism [39]. Other genes
have been described between 2016 and today: 8 in 2016,
15 in 2017 and 15 in 2018. These 60 genes potentially
involved in lipid metabolism are listed in Table 1. Most
of these genes have been identified in human (34) and
mouse (19) with two in both species, the others have
been described in rat (1) or livestock species as pig (5)
and chicken (4).
Mechanisms of action of lncRNAs
The demonstration of a link between the lncRNA of
interest and lipid metabolism can be variable from a
publication to another (Table 1). For 38 of the 60 genes,
a direct or indirect causative effect of the lncRNA on the
lipid metabolism is given in response to an invalidation
and/or an overexpression of the lncRNA. Such experi-
ments were conducted in human (22) or murine (4) cell
cultures or through in vivo experiments, by injection of
viral vector in the tail of mice (11) or more rarely KO
mice (3 with LeXis, MeXis and SRA1 lncRNAs). Out of
these 38 studies, 25 go further to partially or totally de-
cipher the action mechanism (Table 2). For 20 of the 60
genes, the link with lipid metabolism was only based on
a co-expression between the lncRNA and one (several)
transcript(s) or metabolite(s) related to the lipids in re-
sponse to a disease (10), a genotype (6) or a molecule (8)
known to act more or less specifically on lipid metabol-
ism. Finally, 3 studies reported a link with lipid metabol-
ism by GWAS analysis between genetic markers within
or close to the lncRNA and a phenotype associated to
lipid metabolism suggesting that the lncRNA is a poten-
tial causal gene for the phenotype variation.
All the 60 lncRNAs we suggested as involved in lipid
metabolism cover most of the types of action described
so far in the literature for the noncoding genes. As
shown in Fig. 1, these lncRNAs may function as
regulators of the transcription by acting at the DNA
level (Fig. 1a), of the post-transcription and translation
by acting at the RNA level (Fig. 1b) and finally of the
post-translation by acting at the protein level (Fig. 1c).
Concerning the underlying biochemical mechanisms,
most of them are based on lncRNA-RNA or lncRNA-
protein(s) interactions. RNA immunoprecipitation and
pull-down assays [98] have revealed a vast range of in-
teractions between lncRNAs and proteins, proteins that
sometimes interact with other RNAs. Such interactions
constitute real scaffolds that can inhibit or activate dif-
ferent biological processes. At the transcriptional level
(Fig. 1a), different studies showed an action of lncRNAs
on the promoters of genes involved in lipid metabolism.
For example, it is the case of LeXis as reported in a very
comprehensive study conducted by the Tontonoz’s lab
[55] (Fig. 1a, right part): first, LeXis was observed as the
most up-regulated lncRNA in mouse primary hepato-
cytes when treated with GW3965, an agonist to the liver
X receptor (LXR) that mediates cellular and systemic
cholesterol homeostasis and in particular inhibits choles-
terol biosynthesis. The existence of a response element
to LXR was then demonstrated in the LeXis promoter
using luciferase reporter gene experiment and ChIP-
qPCR. Using overexpression of LeXis by adenovirus in-
jection or knockdown experiments in mouse, the au-
thors show that LeXis decreased cholesterol and HDL
and decreased the expression of genes involved in the
cholesterol biosynthesis pathway. LeXis−/− mice also
showed an increase in hepatic cholesterol. Present in the
nucleus, LeXis is suspected to interact on gene transcrip-
tion by modifying protein recruitment on chromatin.
Tontonoz’s lab then demonstrates, using ChIRP/SM and
ChIP experiments, a binding of LeXis on the heteroge-
neous nuclear ribonucleoproteins (hnRNP) RALY, sus-
pected to be a potential transcriptional co-factor. Its
knockdown is responsible for a decrease in cholesterol
levels as well as genic expression in cholesterol biosyn-
thetic pathway. The authors show, using knockdown
and ChIP-qPCR experiments that RALY binds the pro-
moter of different cholesterologenic genes and activates
their expression, activation affected by LeXis through the
modulation of RALY DNA-binding [55].
Other studies have shown an action of lncRNAs on
the transcription. For example, APOA1-AS seems to in-
hibit the transcription of the APO gene cluster (APOA1,
APOC3, APOA4, APOA5) that codes for protein compo-
nents of lipoproteins, by DNA compaction through epi-
genetics mark modulation [41] (Fig. 1a, left part). This
mechanism seems to require the recruitment of the
LSD1 protein known to induce gene silencing through
the removal of active methyl marks, and of the SUZ12
protein, a key component of the polycomb recessive
complex (PRC2) known to mediate chromatin silencing
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Table 1 The 60 genes involved in lipid metabolism and their associated publication
Name in
article
Database name (feature) Normalized
name
Sp. Experiment Tissue/Cell
type
Action Ref.
ANRIL CDKN2B-AS1 (h: 28tr; 3837
bp; 19ex)
ANRIL h Co-effects (6 yr-
adiposity)
Umbilical
cord
↗lnc & ↗fat mass [40]
APOA1-AS APOA1-AS (h: 2tr; 956 bp;
3ex)
APOA1-AS h KD (lnc) HepG2 ↗APO gene cluster: APOA1, APOC3,
APOA4
[41]
APOA4-AS Gm10680 (m: 1tr; 702 bp;
2ex)
APOA4-ASa m KD (lnc) Liver ↘APOA4 & ↘TG, Chol. [42]
FLRL5 m Co-effects (NAFLD) Liver ↗lnc, FADS2, ↘FABP5, LPL, ACMSD, [43]
AT102202 – HMGCR h KD (lnc) HepG2 ↗HMGCR [39]
AT115872 SOD2-OT1 (h: 1tr; 1718 bp;
2ex)
SOD2-OT1a h KD (lnc) HepG2 ↘HMGCR [39]
Blnc1 – Blnc1a m Ov. (lnc) Primary
hepatocytes
↗SREBP1c, FASN, SCD, DGAT2, FABP4,
ABCA1, ABCG5, LPCAT3
[44]
CASIMO1 SMIM22b SMIM22a h Ov. (lnc) MCF-7 ↗Lipid droplet formation [45]
CRNDE CRNDE (h: 24tr; 6325 bp; 2ex) CRNDE h KD (lnc) HCT116,
HT29
↘FASN, DGKA, CDS1, PLCB3, PLCG1,
↗ACADVL, ACOT9, PI4KB
[46]
ORat7 c Co-effects (Se-
deficient diet)
Vein ↗lnc, ↘ACADS [47]
E330013P06 Carmn (m: 2tr; 1778 bp; 3ex) CARMN m Ov. (lnc) RAW 264.7 ↗lipid uptake [48]
FLRL3 Gm11832 (m: 1tr; 432 bp;
3ex)
RAD54B-
AS1a
m Co-effects (NAFLD) Liver ↗lnc, FADS2, ↘FABP5, LPL, ACMSD, [43]
FLRL8 1700067K01Rikb -a m Co-effects (NAFLD) Liver ↗lnc, FADS2, ↘FABP5, LPL, ACMSD, [43]
Gm16551 Gm16551 (m: 5tr; 3162 bp;
3ex)
LINCxxxxa m KD (lnc) Liver ↗ACLY, FASN, SCD & ↗TG [49]
H19 H19 (m: 7tr; 2286 bp; 5ex) H19 m Co-effects (FA) Liver ↗lnc, PTBP1 [50]
HAGLR HAGLR (h: 17tr; 4095; 3ex) HAGLRa h KD (lnc) NSCLC cells ↘FASN & ↘FA [51]
HOTAIR HOTAIR (h: 5tr; 2421 bp; 7ex) HOTAIRa h KD (lnc) CNE2, 5-8F ↘FASN & ↘FA [52]
HOXC-AS1 HOXC-AS1 (h: 2tr; 548 bp;
2ex)
HOXC-AS1a h Ov. (lnc) THP-1 ↗HOXC6 & ↘Chol. [53]
HULC – HULC h Co-effects (HCC) HepG2 ↗lnc, ACSL1, PPARA & ↗TG, Chol. [54]
LeXis 4930412L05Rik (m: 2tr; 1241
bp; 8ex)
LeXis m KO, KD, Ov. (lnc) Liver ↘CYP51A1, FDPS, MVK, MVD, SQLE, IDI1,
LSS, PMVK & ↘Chol.
[55]
LINC01138 LINC01138 (h: 14tr; 2212 bp;
4ex)
LINC01138a h KD, Ov. (lnc) Renal cell
carcinoma
↗SREBP1 activity & ↗lipid desaturation [56]
linc-ADAL LINCADL (h: 1tr; 521 bp; 2ex) LINCADLa h KD (lnc) ASC ↘PPARG, CEBPA, SREBF1, FASN, ELOVL6,
ATGL & ↘TG
[57]
lincRNA-
DYNLRB2–2
LINC01228 (h:1tr; 623 bp;
2ex)
LINC01228 h Co-effects (Ox-
LDL)
THP-1 ↗lnc, GPR119, ABCA1 & ↘Chol., ↗Efflux [58]
LINK-A LINC01139 (h: 7tr; 1579; 2ex) LINK-Aa h Co-effects (lipid-
binding)
TNBC ↗lnc with highest lipid enrichment [59]
LISPR1 – S1PR1-DTa h KD (lnc) HUVEC ↗S1PR1 [60]
lnc_DHCR24 DHCR24-DT (h: 4tr; 440 bp;
2ex)c
DHCR24-
DTa
c Co-effects (fat line) Liver ↗lnc, DHCR24 [20]
lnc18q22.2 LIVAR (h: 1tr; 384 bp; 2ex) LIVAR h Co-effects (NASH) Liver ↗lnc, anti-apoptotic genes [61]
lncACACA – LINCxxxxa h Co-effects (LXR
agonist)
THP-1 ↗lnc [62]
lncARSR LNCARSR d (h: 10tr; 2932 bp;
2ex)
lncARSRa m Ov. (lnc) Liver ↗SREBP1c, FASN, ACC1, SCD, ↘CPT1A [63]
m Ov. (lnc) Liver ↗HMGCR, HMGCS, SQLE, ↘CYP7A1 &
↗Chol.
[64]
lncFASN LINC01970 (h: 1tr; 1810 bp;
2ex)
LINC01970a h Co-effects (LXR
agonist)
THP-1 ↗lnc [62]
lnc-HC – lnc-HC r KD, Ov. (lnc) Liver, CBRH- ↘CYP7A1, ABCA1 & ↘TG, Chol. [65]
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Table 1 The 60 genes involved in lipid metabolism and their associated publication (Continued)
Name in
article
Database name (feature) Normalized
name
Sp. Experiment Tissue/Cell
type
Action Ref.
7919
lncHR1 AC023161.1 d (h: 1tr; 420 bp;
2ex)
lncHR1 m Ov. (lnc) Liver ↘SREBP1c, FASN, ACACA & ↘TG [66]
lnc-KDM5D-4 – LINCxxxxa h KD (lnc) HepG2 ↗LPIN2 & ↗Lipid droplet formation [67]
lnc-leptin – lnc-leptina m KD (lnc) Primary
adipocyte
↘LEP [68]
lncLSTR C730036E19Rik (m: 1tr; 1102
bp; 5ex)
lncLSTR m KD (lnc) Liver ↗APOC2, ↘CYP8B1 & ↘TG, Glucose [69]
lncLTR NONGGAG001747.2 (c: 1tr;
776 bp; NA)
lncLTRa c GWAS (serum TG
content)
– SNP in lncLTR locus [70]
lncSHGL B4GALT1-AS1 d (h: 3tr; 3752
bp; 4ex)
lncSHGLa m KD, Ov. (lnc) Liver ↗ACACB, ↘FASN, SREBP1 & ↘FA, lipolyse [71]
lncSREBF1 SMCR2 (h:1tr; 564 bp; 4ex) SMCR2a h Co-effects (LXR
agonist)
THP-1 ↗lnc [62]
LNMICC AC009902.2 (h: 2tr; 620 bp;
2ex)
LNMICCa h KD, Ov. (lnc) HeLa229 ↗ACACA, FASN, FABP5, ↘ACOX1, CPT1A
& ↗TG, PL
[72]
LOC100506036 CNNM3-DT (h: 1tr; 415 bp;
2ex)
CNNM3-DT h KD (lnc) Jurkat cells ↘SMPD1, NFAT1 [73]
LOC157273 AC022784.6 (h: 1tr; 559 bp;
1ex)
LINCxxxxa h GWAS (lipid-traits) – ↗lnc / SNP in the lncRNA locus [74]
MALAT1 MALAT1 (h: 17tr; 1519 bp;
2ex)
MALAT1 h KD (lnc) HepG2 ↗SREBP1c & ↗TG, Chol. [75]
MEG3 MEG3 (h: 50tr; 4867 bp; 2ex) MEG3 h,
m
Ov. (lnc) Liver
HEK-293 T
↗CYP7A1, CYP8B1, FXR, SREBP1c, ↘SHP [76]
m KD (lnc) Liver ↘TG [77]
m Co-effects (NAFLD) Liver ↗lnc, NRF2, ↘miR-136 & ↘serum lipid [78]
MeXis AI427809 (m: 4tr; 2033 bp;
2ex)
MeXis m KO, Ov. (lnc) Liver,
Macrophage
↗ABCA1 & ↗Chol. efflux [37]
NEAT1 NEAT1 (h: 9tr; 3341 bp; 2ex) NEAT1 h KD (lnc) THP-1 ↘TNFa, ↗CD36, OLR1 & ↗lipid uptake [79]
h KD (lnc) HCC ↘ATGL, PPARa, ↗miR-124-3p [80]
OLMALINC OLMALINC (h: 36tr; 5893 bp;
5ex)
OLMALINCa h Co-effects
(obesity)
Adipose ↘lnc, ↗lipid metabolism genes [81]
h KD (lnc) HepG2 ↗SREBP2-dependent gene, ↘SREBP1
pathway genes
[82]
PLA2G1Bat1 ENSGALG00000041755 (c:
3tr; 2101 bp; 3ex)
LINCxxxxa c Co-effects (Se-
deficient diet)
Vein ↘lnc, ↗PLA2G1B [47]
PVT1 PVT1 (h:182tr; 1699 bp; 8ex) PVT1a h KD (lnc) U2OS
MG-63
↗miR-195, ↘FASN [83]
RNCR3 Mir124a-hg (m: 4tr; 4103 bp;
4ex)
RNCR3a m KD (lnc) Plasma ↗TG, Chol. [84]
RP1-13D10.2 AL021407.3 (h: 1tr; 486 bp;
1ex)
LINCxxxxa h Ov. (lnc) Huh7, HepG2 ↗LDLR & ↗LDL, ↘ApoB [85]
RP5-833A20.1 NFIA-AS1 (h: 7tr; 384 bp; 4ex) NFIA-AS1 h KD, Ov. (lnc) THP-1 ↗miR-382, ↘NFIA & ↗Chol. [86]
SNHG14 Snhg14 (m: 15tr; 6861 bp;1
2ex)
SNHG14 m KD, Ov. (lnc) BV-2 ↘PLA2G4A [87]
SNHG16 SNHG16 (h: 13tr; 3607 bp;
3ex)
SNHG16a h KD (lnc) HCT119 ↘SCD, PCSK9, SQLE, ACLY, INPP5D,
HSD17B7
[88]
SPRY4-IT1 SPRY4-AS1 (h: 7tr; 1293 bp;
5ex)
SPRY4-IT1a h KD (lnc) HEM-1 ↘DGAT2, GPAT3 & ↘Acyl Carnitine, FA,
TG
[89]
SRA Sra1b (m: 2tr; 1299 bp; 4ex) SRA1 m KO (lnc) Liver ↗ATGL [90]
m KO (lnc) Liver ↘PPARA, PPARG, FABP4, SCD & ↘TG, FA [91]
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through H3K27 trimethylation [41]. Indeed, the APOA1-
AS depletion in HepG2 cells increased the active histone
H3K4me3 marks at the APOA1 promoter in parallel to a
significant decrease of LSD1 occupancy. APOA1-AS de-
pletion also decreased the repressive histone H3K27me3
marks at the APOA1 promoter that coincided with a
marked reduction of SUZ12 occupancy in this region
[41]. A second example of lncRNA action on DNA com-
paction is Lnc-leptin [68] (Fig. 1a, middle part). By using
chromatin conformation capture experiments, a direct
interaction was detected between lnc-leptin and the LEP
(leptin) gene, which codes for a major adipokine secreted
by white adipocytes and functioning as an energy sensor
to regulate energy homeostasis. This “lnc-leptin – leptin
promoter” interaction occurred at the enhancer region
of LEP and it was diminished upon lnc-leptin knock-
down in mature adipocytes.
At the post-transcriptional level, some lncRNAs seem
to play a role in the maturation of RNAs such as
lncRNA uc.372 (Fig. 1b, left part) which prevents the
maturation of a pri-miRNA by camouflaging the area
targeted by the Drosha protein [93]. On mature RNAs,
the so called “competing endogenous RNA (ceRNA)”
role of lncRNAs resembles that of a sponge for small
RNAs regulating the mRNA target of small RNAs (Fig.
1b, middle part). Among the lncRNAs involved in lipid
metabolism, NEAT1 [80], SNHG16 [88] and PVT1 [83]
are endogenous competitors of ATGL, SCD and FASN
transcripts, respectively. Sometimes, lncRNA-protein
complexes target a mRNA and thus regulate its stability
(lnc-HC [65], H19 [50], MEG3 [76], NEAT1 [79],
APOA4-AS [42]) or its translation (lncSHGL [71]) (Fig.
1b, right part). LncRNAs can bind via their three-
dimensional conformation, involving one or more pro-
teins in the structure (Fig. 1c). They can bind via their
sequence RNA of hnRNP such as SPRY4-IT1 [89] (Fig.
1c, left part). They can also form protein scaffolds such
as Blnc1 which associates with EDF1, LXRα and
hnRNPU [95] or linc-ADAL which associates with
IGF2BP2 and hnRNPU [57] (Fig. 1c, left part). These
protein scaffolds do not yet have a well-defined mechan-
ism of action. Some publications have gone further by
highlighting the interest of this complex. For example,
lncRNA protein complexes can modulate the half-life of
the proteins involved in the complex, such as MALAT1
which binds to SREBP1c in order to stabilize it [75] (Fig.
1c, middle part), or they can modulate its function, such
as LINK-A which binds to PIP3 and intensifies its inter-
action with Akt [59] (Fig. 1c, right part) or modify its
cell location as illustrated by NRON [97]. Another role
of lncRNA [99] is that of hosting small RNAs (Fig. 1d).
SNHG16 [88] illustrates very well this role because it
hosts 3 small nucleolar RNAs (snoRNA) SNORD1A,
SNORD1B and SNORD1C which are positioned within
the introns in the sense direction of the lncRNA, thus
benefiting from the co-transcription with the host
lncRNA. Finally, lncRNAs can also host small ORFs (Fig.
1e) allowing the translation of small peptides. CASIMO1
is a perfect example, lncRNA CASIMO1 hosts the se-
quence of a small transmembrane peptide that interacts
directly with the SQLE protein and modulates the for-
mation of lipid droplets [45].
Table 1 The 60 genes involved in lipid metabolism and their associated publication (Continued)
Name in
article
Database name (feature) Normalized
name
Sp. Experiment Tissue/Cell
type
Action Ref.
TRIBAL AC091114.1 (h: 2tr; 1272 bp;
3ex)
TRIBAL h GWAS (TG) – SNP in TRIBAL locus [92]
uc.372 – RALGAPA1-
AS1a
h,
m
Ov. (lnc) Liver, HepG2 ↗ACACA, FASN, SCD, CD36 & ↗TG, Chol. [93]
XLOC_011279 – LINCxxxxa p Co-effects (fat line) Adipose ↗lnc, LPIN1 [94]
XLOC_013639 – LINCxxxxa p Co-effects (fat line) Adipose ↗lnc, SCD [94]
XLOC_014379 – NF1-IT1a p Co-effects (fat line) Adipose ↗lnc, SCD [94]
XLOC_019518 – RNF7-DTa p Co-effects (fat line) Adipose ↗lnc, SCD [94]
XLOC_064871 – LINCxxxxa p Co-effects (fat line) Adipose ↗lnc, TRIB3 [94]
agenes that not described in previous reviews dedicated to lncRNA in lipid metabolism. Database name (feature): name used in the Ensembl database for
human (h), mouse (m) or chicken(c) gene database depending on the species in which the lncRNA has been studied (see column “sp”), the database was
NONCODE for lncLTR; between brackets, the following features are provided: transcript number; the size (in bp) and the exon number (ex) indicated only for the
transcript having the highest size and noted in the database ‘genecode basic’ and/or ‘TSL1 or TSL2’ (indexes giving the transcript support level)); b: lncRNA with a
double “protein coding-lncRNA” classification (see result section); c: human name for lncRNA discovered in chicken and for which a non ambigous 1-to-1
orthologue was found; d: human name if no mouse name was found in Ensembl database. Normalized name: new names according to the HUGO gene
nomenclature committee [32]. “Sp.” column mentions the species studied: “h”, “m”, “r”, “p” and “c” for human, mouse, rat, pig and chicken, respectively. The
“Experiment” column refers to three type of experiments: 1. a direct or indirect causative effect of the lnc on the lipid metabolism through either an invalidation
of the lncRNA by knockout (KO) or knockdown (KD) or an overexpression (Ov.) performed in vitro in cells or in vivo in mice; in the “action” column, we have
provided the effects of the lnc overexpression when there were Ov and KD/KO experiments; 2. a “Co-effect “refers to a modulation of the quantity of the lncRNA
in parallel with the quantity of transcripts or metabolites known to be involved in lipid metabolism; this co-modulation being induced in response to a particular
factor (given between brackets) as disease, genotype/line, diet or molecule known to modulate lipid metabolism; 3. a” genome-wide association study” analysis
(GWAS). The information in the “Tissue/cell type” and “Action” columns correspond to the experiment
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New names proposed for misnamed lncRNAs
When a new field is explored, the associated nomencla-
ture requires a certain amount of time to be standard-
ized; this was the case for the nomenclature associated
with protein-coding genes and of course it is also the
case for the long noncoding genes. When referring to
the official HUGO gene nomenclature committee
(HGNC), it appears that some lncRNA were not prop-
erly named, which can lead to misunderstandings. In-
deed, the HGNC lists very precise rules on how to name
lncRNA [32]. These can be summarized in seven points
(Fig. 2): 1. if the lncRNA function is well described, the
lncRNA takes an abbreviated name symbolizing its func-
tion, e.g. LeXis for liver-expressed LXR-induced se-
quence, lncLSTR for liver-specific triglyceride regulator.
In the case of unknown function, the lncRNA takes the
symbol gene name of the gene harboring it enriched by
a suffix describing its genomic location: 2. the ‘Intronic’
and ‘sense’ lncRNA genes are appended with -IT for In-
tronic Transcript (e.g. SPRY4-IT1); 3. the ‘sense’ and
overlapping a protein-coding gene lncRNA gene are
appended with the suffix -OT for Overlapping Tran-
script (e.g. SOD2-OT1); 4. the ‘Antisense’ lncRNA gene
are appended with the suffix -AS for Antisense (e.g.
APOA1-AS, NFIA-AS1). 5. Close intergenic divergent
lncRNA (< 1 kb) transcribed in the opposite direction to
nearby protein-coding genes takes the gene symbol
name appended with the suffix -DT for Divergent Tran-
script (e.g. DHCR24-DT). 6. Other intergenic lncRNAs
take the name LINC followed by a number assigned by
HGNC committee (for human genes). 7. An exception
exists for lncRNAs hosting small noncoding RNAs that
take the name of the small hosted RNA appended with
the suffix HG for Host Gene (e.g. SNHG16). Finally a
long noncoding transcript that has common splice junc-
tions with protein-coding transcripts is considered as an
additional isoform and therefore belongs to this protein-
coding gene [32]. In spite of this approved nomenclature
guidance, some lncRNAs are still misnamed. For ex-
ample the lncRNAs described by Tristán-Flores et al.
Table 2 Mechanisms of action reported for 25 lncRNAs
Name Sp. LncRNA action Ref.
APOA1-AS h Histone mark modification via LSD1 et SUZ12 (PRC2) [41]
APOA4-AS m Complex lnc:HuR et APOA4 mRNA [42]
Blnc1a m Complex lnc:hnRNPU / Complex lnc:EDF1, lnc:LXRa [95]
CASIMO1a h Small protein CASIMO1 interacts with SQLE protein [45]
H19 m Complex lnc:PTBP1 which targets SREBP1c mRNA and protein stability and transcriptional activity [50]
LeXis m Complex lnc:RALY (hnRNP) which targets SREBP2, HMGCR, CYP51A1, FDPS promoters [55]
LINC01138 h Comple lnc:PRMT5 which targets SREBP1 in order to regulate its arginine methylation and to stabilize SREBP1 mRNA [56]
linc-ADALa h Complex lnc:IGF2BP2 and hnRNPU [57]
LINK-Aa h Complex lnc:PIP3 increases interaction with Akt [59]
lnc-HC r Complex lnc:hnRNPA2B1 which targets CYP7A1/ABCA1 mRNAs [65]
Lnc-leptina m Loop between LEP and its enhancer (near lnc:leptin locus) [68]
lncLGRa m Complex lnc:hnRNPL which targets GCK promoter [96]
lncLSTR m Complex lnc:TDP-43 which targets CYP8B1 promoter [69]
lncSHGLa m Complex lnc:hnRNPA1 which targets CALM mRNA to increase its translation [71]
LNMICCa h Complex lnc:NPM1 which targets FABP5 promoter [72]
MALAT1 h Complex lnc:SREBP1c which stabilizes nuclear SREBP1c protein [75]
MEG3 h,m Complex lnc:PTBP1 which targets SHP mRNA for its decay [76]
MeXis m Complex lnc:DDX17 which targets ABCA1 promoter [37]
NEAT1 h Complex lnc:NONO:CD36 mRNA [79]
h ceRNA (miR-124-3p which targets ATGL) [80]
PVT1a h ceRNA (miR-195 which targets FASN) [83]
RALGAPA1-AS1a h,m Stop maturation of pri-miRNA (pri-miR-195/pri-miR-4668) [93]
S1PR1-DTa h Complex lnc:ZNF354C which inhibits its repressive activity [60]
SNHG14 m ceRNA (miR-145-5p which targets PLA2G4A) [87]
SNHG16a h ceRNA (multiple miRNA which target SCD) & Complex lnc:HuR [88]
SPRY4-IT1a h Complex lnc:Lipin2 [89]
agenes not described in previous reviews
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[62] have been misnamed in lncACACA, lncFASN and
lncSREBF1, although they are neither sense nor anti-
sense of the ACACA, FASN and SREBP1 genes. The
lncRNA depletion by KO experiments affected the ex-
pression levels of the three genes, which again does not
allow to use these names.
We propose to rename some lncRNAs according to
the HGNC rules whatever the species (Table 1, column
3). Seven lncRNA have been renamed according to the
nearby protein-coding gene: lnc_DHCR24 [20] in
DHCR24-DT, AT115872 [39] in SOD2-OT1, XLOC_
014379 [94] in NF1-IT1, FLRL3 [43] in RAD54B-AS1,
XLOC_019518 [94] in RNF7-DT. We have also renamed
two other genes: LISPR1 (long intergenic noncoding
RNA antisense to S1PR1) [60] in S1PR1-DT, and uc.372
(ultra-conserved 372) [93] which has a generic name and
should be rather called RALGAPA1-AS1. We have re-
stored the official and standardized names, LINC01970
and SMCR2 (Smith-Magenis syndrome Chromosome Re-
gion, candidate 2), for the two lncFASN and lncSREBF1
genes [62] respectively. All other XLOC_013639, XLOC_
011279, XLOC_064871 [94], lncACACA [62],
LOC157273 [74], Gm16551 [49], PLA2G1Bat1 [47] and
lnc-KDM5D-4 [67] genes should have a standard name
of the type LINC#####. Finally, the lncRNA AT102202
has several common splice junctions with the HMGCR
protein-coding gene and should therefore be considered
as a HMGCR isoform rather than a lncRNA new gene.
Note that the knockdown of this isoform in HepG2 cells
was described by Liu et al. to increase the expression
level of the gene encoding HMGCR due to the presence
of several HMGCR isoforms with different expression
patterns [39]; although the authors missed to specify
which isoform was targeted by siRNAs and which one
was up-regulated (see Additional file 1). According to
this figure, the knockdown of the AT102202 isoform
should lead to an absence of HMGCR functional
protein.
In some cases, a gene is named with several aliases be-
tween species. This is the case for lncSHGL in mouse
known as B4GALT1-AS1 in human which were both
mentioned in Wang et al. [71]. Naming problems also
exist within the same species. For example, the NCBI
mouse gene named Gm30838 by the MGI (Mouse Gen-
ome Informatics), is double named in Lo et al. lnc-
ORIA9 and lnc-leptin [68]. Similarly, the human
ENSG00000266304 lincRNA gene, firstly known as
RP11-484 N16.1, was named lnc18q22.2 by Atanasovska
et al. [61] and finally officially renamed LIVAR. Due to
their recent studies, we found some genes in databases
with an “ID” name instead of its common names used in
the literature (e.g. AC023161.1 instead of lncHR1 [66]).
Fig. 1 The different mechanisms of action of lncRNAs. a Mechanisms with effect at transcriptional level, b at post-transcriptional level and (c) on
proteins. d LncRNAs with a role as small noncoding RNA host. e LncRNAs with translational activity through a small ORF. In red, lncRNA; in green,
mRNA; in blue, miRNA; the green, yellow and blue oval spheres are proteins. The genes in bold are those mentioned in this review, the others
are examples from research fields other than lipid metabolism: SAF66 and NRON [97]
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Fig. 3 Verification of the ALDBGALG00000000505049 and FLRL7 gene models with their neighboring SCD and FADS2 genes in chicken and mouse.
a, d Model of protein-coding genes are from Ensembl v.92 and models of lncRNA are from the article of Fan et al. [101] that used ALDB v1.0, a
lncRNA database (a for ALDBGALG00000000505049) and from the article of Chen et al. [43] that used their own models (d for FLRL7). Primers
(black arrows) were design in order to amplify a fragment (red line) specific of lncRNA gene (I), of coding-protein gene (IV), of intergenic region
(III) and of a fragment linking both genes (II). The expected sizes have been specified (black for RNA; red for DNA) according to the models. b, e
Electrophoretic gels with the lengths of the amplicons, showing the existence of a unique gene, the lncRNA being an extension of the protein-
coding gene. c, f New experimentally corrected models for the protein-coding gene
Fig. 2 HGNC decision tree for naming lncRNAs according to the Wright’s schema [32], here updated by including divergent lncRNA and lncRNA
hosting small noncodingRNA
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Other problems are due to some articles that use
lncRNA gene names without referring to any database:
the most classical examples are XLOC/TCONS names
reflecting experiment-dependent naming from Cufflinks
(e.g. pig new genes in Huang et al. [94]) but other names
exist such as AT102202 [39] which does not refer to any
easily detectable source because it is a contraction of the
NONCODE ID NONHSAT102202.
Detailed examination of model architecture
It is important to note that the vast majority of RNAs
present in the databases are only predictions and that
their structure has only very rarely been validated ex-
perimentally. A lncRNA model localized close to a
protein-coding gene and in a same strand of this latter
can be spurious; it is possible to be an extension of the
protein-coding gene due to the difficulty of modelling
the ends of transcripts [100]. We detected two lncRNA
in this case. The ALDBGALG0000005049 lncRNA is
close (~ 1 kb from the SCD 3’UTR) and on the same
strand of the SCD gene (Fig. 3a), that encodes the
stearoyl-CoA desaturase enzyme that catalyzes the rate-
limiting step in the formation of monounsaturated fatty
acids. Fan et al. described in chicken myoblasts that the
inactivation of the ALDBGALG0000005049 gene by
siRNA led to an under-expression of the SCD gene and
a modulation of other genes such as PPARA, PPARB
and PPARG (Peroxisome Proliferator Activated Recep-
tor) [101] making this lncRNA a potentially important
lncRNA in lipid metabolism. However, we propose here
to verify the existence of the ALDBGALG0000005049
gene using chicken liver cDNA treated by DNAse using
genomic DNA as control. The amplification of the inter-
genic region “SCD-ALDBGALG0000005049”, confirmed
by sequencing, clearly shows the existence of a transcript
that overlaps the two genes (Fig. 3b), demonstrating that
ALDBGALG0000005049 and SCD are in fact a single
gene (Fig. 3c). We report another case, the lncRNA
FLRL7, located very close (150 nt from the FADS2
3’UTR) and on the same strand of the FADS2 (fatty acid
desaturase 2) protein-coding gene (Fig. 3d) and whose
expressions were both up-regulated in the liver of
NAFLD mouse according to Chen et al. [43]. We dem-
onstrated using mouse liver cDNA treated by DNAse
that FLRL7 and FADS2 genes are a unique gene (Fig.
3e), thus extending the 3′ UTR end of the FADS2 gene
(Fig. 3f).
Conservation between phylogenetically distant species
Gene conservation during evolution, especially between
phylogenetically distant species suggests an important
functional role for these genes. Conservation of function
of lncRNA across species was tested in some studies,
showing a function retained despite a minor sequences
conservation [29]. However the task remains difficult be-
cause of the poor conservation of lncRNA sequences be-
tween phylogenetically distant species as opposed to
protein-coding genes, suggesting a more rapid evolution
of lncRNA during evolution [14, 20, 27]. Therefore, we
propose here to carry out orthologous lncRNA searches
between phylogenetically distant species (chicken and
mammals) using an approach based on the genome syn-
teny as already presented in Muret et al. [20] and Foissac
et al. [28] (see Materials & Methods). Even if this man-
ual approach is time-consuming, we investigated the
whole 60 long noncoding genes involved in lipid
metabolism.
Out of the 60 lncRNA genes mentioned in the Table
1, five genes satisfy the aforementioned criteria between
chicken and man (or mouse) and can therefore be con-
sidered as orthologous between the species analyzed:
there are CRNDE, DHCR24-DT, NFIA-AS1, PVT1 and
SRA1. Their roles are described in more detail below.
We can note that 5 other lncRNAs are potentially ortho-
logous since 1. they correspond positionally to several
lncRNAs in the other species or 2. the gene environment
has slightly evolved, e.g. a new coding gene appear in
locus or the distance between genes are different be-
tween species. These lncRNAs are lncACACA,
DYNLRB2–2, MeXis, PLA2G1Bat1 and TRIBAL. Table 3
shows the genomic positions in human, mouse and
chicken of these 10 lncRNA. These lncRNAs potentially
play important roles in lipid metabolism since they act
on the expression of key genes of this metabolism as key
enzyme genes (FASN, SCD, ACADS, ACADVL, ATGL),
lipid transport genes (ABCA1, FABP4) or lipid metabol-
ism transcription factor genes (PPARA, PPARG).
CRNDE (ColoRectal Neoplasia Differentially
Expressed) is a lncRNA divergent with respect to the
IRX5 gene, at 2 kb and 1.2 kb in human and chicken, re-
spectively. In chicken, it has been described as ORat7
[47] (ALDBGALT0000001763). Composed of 6 to 9
exons in chicken and 6 exons in human, CRNDE is
mainly noncoding but some isoforms are known in hu-
man to code for small proteins [102]. In human, CRNDE
knockdown by siRNA in colorectal cancer cell lines leads
to an under-expression of FASN, and an overexpression
of ACADVL and ACOT9, two genes involved in lipid ca-
tabolism [46].
Lnc_DHCR24, renamed in DHCR24-DT (Table 1), is a
lncRNA divergent with respect to the DHCR24 gene
coding for a key enzyme of the cholesterol synthesis. We
have modelled this transcript for the first time in 2017
in chicken and located a possible orthologue in human
[20]. The intergenic region is very small, i.e., 200 bp in
human and 300 bp in chicken [20]. In a previous study,
we have suggested that these two genes are likely to be
co-regulated by a bi-directional promoter, because of
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their high hepatic co-expression in several chicken lines
(layers and broilers) analysed at different ages (young
and, adult stage) [20].
NFIA-AS1 is an intronic antisense lncRNA of the
NFIA gene (Nuclear Factor I A). Composed of 4 to 7
exons, it is found on the second intron of NFIA gene in
human as well as in chicken. It negatively regulates in
THP-1 cells the expression of the NFIA gene by a nega-
tive feedback mechanism with the transcription factor
NF1A binding the promoter of NFIA-AS1 to activate it
[86]. LncRNA NFIA-AS1 (also called RP5-833A20.1) is
induced by a high level of oxidized and acetylated LDL
[86]. These two genes (NFIA-AS1 and NFIA) appear to
regulate the homeostasis of cholesterol (LDL, HDL,
VLDL) and inflammatory cytokines (IL-1β/6, TNF-α and
CRP) in Apo−/− mice [86].
PVT1 (Plasmacytoma Variant Translocation 1) is a
same strand lncRNA with respect to the MYC nearest
protein-coding gene. Modelled in the NCBI databases of
human, mouse and rat, the two genes are separated by
50-60 kb in these three species. In the chicken, we also
found it at the same distance (56 kb) of the MYC gene.
PVT1 in human is a competitive endogenous lncRNA by
acting as a sponge of MIR-195 in osteosarcoma cells
[83]. It upregulates BCL1 and BCL2, two genes playing
roles in the control of cell cycle and apoptosis, but also
FASN, one of the key lipogenic enzymes.
SRA1, better known by its first name SRA (Steroid Re-
ceptor Activator), is one of the first lncRNA described in
human (1999) [103]. Its functional RNA acts as a steroid
receptor coactivator. It can coactivate androgen receptor
(AR), estrogen receptors (ERα, ERβ), progesterone re-
ceptor (PR), glucocorticoid receptor (GR), thyroid hor-
mone receptor (TR) and retinoic acid receptor (RAR)
[104]. As early as 2003, it was demonstrated that its
codes for a functional SRAP protein improving the
trans-activation of PPARG and genes coding for AR and
GR [105]. In Human, as in mouse or other species, this
double “protein coding-lncRNA” classification exists
[106]. In this review, we are only interested in its non-
coding isoform. SRA1 is an antisense exonic lncRNA of
the gene coding for ANKHD1 in human. Currently, we
do not know if SRA1 has noncoding isoforms in chicken
but a coding isoform is present in Ensembl database
(ENSGALG00000040453). Using a mouse SRA1 KO, the
noncoding SRA1 isoform seems to regulate in the liver
the expression of genes involved in lipid metabolism as
PPARA, PPARG, FABP4 and SCD by a mechanism still
unknown [91]. In 2016, the same team showed that in
liver, the noncoding SRA1 isoform positively regulates
the expression of PNPLA2. PNPLA2 codes for an en-
zyme that plays a role in lipid hydrolysis that if under
expressed leads to the progressive fatty liver steatosis
[90].
For the previous 5 lncRNA found to be preserved be-
tween human and chicken, two model species, xenope
and zebrafish, and three livestock species, goat, bovine
and pig, have been added to the syntenic conservation
Table 3 The 10 lncRNAs potentially conserved between human/mouse and chicken genomes
LncRNA Hsa.ID Hsa.position Mmu.ID Mmu.position Gga.ID Gga.position
CRNDE ENSG00000245694 16:54845189–54,
929,189(−)
ENSMUSG00000031736 8:92326033–92,
356,120(−)
XLOC_003575 [47] 11:4285705–4,316,
300(+)
DHCR24-DT ENSG00000233203 1:54887563–54,
888,850(+)
– – ENSGALG00000035342 8:25343117–25,
344,661(+)
PVT1 ENSG00000249859 8:127794533–128,
101,253(+)
ENSMUSG00000097039 15:62037986–62,
378,096(+)
ENSGALG00000033453 2:139905946–139,
947,148(+)
NFIA-AS1 ENSG00000237853 1:61248945–61,
253,510(−)
RefSeq:102637398 4:98018556–98,
024,773(−)
NONGGAG010741 8:27269736–27,
278,903(−)
SRA1 ENSG00000213523 5:140537340–140,
558,252(−)
ENSMUSG00000006050 18:36666681–36,
679,366(−)
ENSGALG00000040453 13:1649170–1,650,
955(−)
DYNLRB2–2 ENSG00000261082 16:79798050–79,
827,150(−)
ENSMUSG00000110620 8:115971635–115,
972,071(−)
Mult. ALDB Models ~ 11:14928493–15,
189,801(−)
lncACACA Unknown 17:36810109–36,
810,324(−)
– – Mult Ens. Models ~ 19:8345185–8,
375,056(−)
MeXis TCONS_00016111
[55]
~ 9:105092000–105,
108,500(+)
ENSMUSG00000086712 4:53261356–53,
270,232(−)
Mult. ALDB Models ~Z:54833466–54,
863,390(−)
PLA2G1Bat1 – – ENSMUSG00000087292 5:115359078–115,
422,863(+)
ENSGALG00000041755 15:9358431–9,
366,570(+)
TRIBAL ENSG00000253111 8:125466939–125,
541,373(+)
– – Mult. ManyDB Models ~ 2:138972973–
138,996,132(+)
In bold: species where genes were firstly identified. Other: species where the “orthologous” gene was manually found. “Hsa”, “Mmu” and “Gga” refer to Homo
sapiens, Mus musculus and Gallus gallus. “ID” is the Ensembl, NCBI, NONCODE or Cufflinks provisional ID (with article reference in brackets). Position refer to the
chromosome position in GRCh38.p12 human assembly, GRCm38.p6 mouse assembly and Gallus_gallus-5.0 chicken assembly
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analysis to better appreciate the conservation in verte-
brates. Note that the model species xenope (370Myr)
and zebrafish (440Myr) are more phylogenetically distant
from human than the chicken (320Myr) (Fig. 4a). We
have selected also cattle and pig because they are eco-
nomically important livestock species, widely consumed
in the world. To study conservation, in addition to the
public reference Ensembl and NCBI databases, we used
the lncRNA catalogues that we recently published for
these species [28]. The Fig. 4b shows the conservation of
the 5 lncRNA across the 8 species. In the current state
of the genome annotation, two genes DHCR24-DT and
NFIA-AS1 are preserved only within some amniotes,
despite the fact that the two DHCR24 and NFIA neigh-
boring protein-coding genes were conserved in other
vertebrates. Such observations can be due to a poor gene
annotation in the species were these two long noncoding
genes were not identified. Another hypothesis is a con-
vergent evolution in mammals and birds that could ex-
plain why it is present in chicken and not in other
mammals that are evolutionary closer to human and
mouse. On the other hand, CRNDE is found in all
tetrapods with robust reliability and the cluster of IRX
genes in which CRNDE is located is very strongly pre-
served in vertebrates [109]. Finally, two genes are con-
served in all vertebrates: PVT1 and SRA1 which are in
particular involved in FA biosynthesis through the regu-
lation of two key enzymes FASN and SCD respectively.
We then studied the expression of these five lncRNA
in three tissues known to be involved in lipid metabol-
ism, using human [110] and chicken samples. The tis-
sues chosen were the liver and adipose tissue as key
organs/tissues for lipid synthesis and triglyceride storage.
The third tissue is the hypothalamus because of its cen-
tral role in energy homeostasis via the regulation of food
intake and energy expenditure [11]. The chicken embryo
was also studied because many lncRNAs were described
as expressed during embryonic development [111–113].
The expression of the 5 lncRNAs is shown in Fig. 5a. In
chicken the 5 lncRNAs were overexpressed in the 3 tis-
sues and in the embryo compared to the total lncRNA
expressions (t-test; p-value < 0.05), the median of their
expression being equivalent to the third quartile of the
total lncRNA expression (Fig. 5b). LncRNAs are known
Fig. 4 Genomic conservation in 8 species of the five lncRNA previously found as conserved between human and chicken. a Tree of genome
evolution in vertebrates based on Kumar and Hedges studies [107, 108]. b Conservation of the five lncRNA (yellow) through the animal kingdom
in relation to their genomic environment: protein-coding gene (blue). The distances between the intergenic entities are in bases
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to be very poorly expressed compared to protein-coding
genes (10 to 100 times less [14, 20]). This observation
shows that the lncRNAs described so far are generally
more expressed than the whole modelled lncRNAs.
PVT1 and SRA1 were well expressed in all 3 tissues,
both in human and chicken. DHCR24-DT was overex-
pressed in the liver of both species compared to the
other tissues. On the contrary, CRNDE was not
expressed in human, at least in the tissues and samples
analyzed. Finally, NFIA-AS1 was not expressed in any of
the 3 tissues analyzed, whatever the species. This does
not preclude for expression in other tissues, because Hu
et al. have shown a link between this gene and lipids in
macrophage cells [86].
Discussion
To our knowledge, previous reviews taken together de-
scribed 27 lncRNAs involved in lipid metabolism. An ex-
tensive research has allowed us to report 33 additional
lncRNAs, the majority of which identified in human or
mouse, resulting in a total of 60 long noncoding genes
having a role in lipid metabolism. Such a research has to
be meticulous because of the multiple aliases intra and
between species and is tedious and time-consuming.
In addition to gathering these 60 genes as related to
the lipid metabolism, we demonstrated experimentally
that two lncRNA close and on same strand with the
SCD and FADS2 protein-coding genes and called by the
authors as ALDBGALG00000000505049 and FLRL7 re-
lated to the lipid metabolism, were spurious. We also
made a lncRNA nomenclature revision and propose to
rename some genes according to the official rules of the
HUGO gene nomenclature committee [32].
We then performed a comparative analysis to identify
orthologous genes between phylogenetically distant spe-
cies. Such a approach allows to make use of the know-
ledge obtained in one species to infer the presence on
lncRNAs in other species not examined so far. In par-
ticular, it facilitates the understanding of the biological
role by working on species in which gene manipulations
are easier. Unfortunately, this research is difficult for
lncRNAs because these genes are very poorly conserved
in sequence between relatively distant species; such re-
search required synteny approaches to study the conser-
vation of the local genomic structure around the gene of
interest. We identified, out of the 60 lncRNAs, 5
lncRNAs conserved within amniotes (320Myr), including
two conserved within vertebrates (440Myr). Such results
are consistent with other studies; some articles reported
less than 20% of lncRNAs conserved across mammals
[114, 115]. Interestingly, we showed that lncRNAs de-
scribed so far are more expressed compared to the
whole lncRNAs present in the gene databases; the rea-
son is likely technical since it is easier to work on
lncRNAs that are more expressed.
Conclusions
Such a catalogue of 60 genes is interesting, first, by
providing new regulators of a complex lipid metabol-
ism known to be highly regulated at the mRNA levels
[42, 76]. Second, because the lipid metabolism is par-
ticularly important in human health through the nu-
merous diseases related to this metabolism (obesity,
cardiovascular diseases, hepatic steatosis ...). Third,
because this metabolism is also important in livestock
species where it is linked to economically important
traits, such as intramuscular fat content, meat quality
Fig. 5 Expression of lncRNA in embryo, liver, adipose tissue and hypothalamus in human and chicken. a Expression of the 5 lncRNA conserved
between human and chicken. b Expression of all lncRNAs (pale colors) in the different tissues against all the 5 lncRNA studied here. Embryo (E),
liver (L), adipose tissue (A), hypothalamus (H). Top: expression in human with n = 3 (embryo not represented), bottom: expression in chicken with
n = 16. **: p value< 5% ***: p value< 1%
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traits [116–118] and ectopic fat deposition and eco-
nomic carcass values. It should be noted that more
than 2/3 of the 60 lncRNAs reported in this review
were discovered in the last 2 years and we have no
doubt that this first set will be rapidly enriched in the
coming years.
Methods
Literature review
The state of the art regarding lncRNA potentially in-
volved in lipid metabolism was obtained by expert cur-
ation of the literature database Pubmed. In this way,
lipid metabolism was defined as the including synthesis,
degradation and transport of different types of lipids,
with a particular interest for fatty acids and cholesterol.
The keyword literature search was therefore conducted
by combining the terms “lncRNA” and one of the fol-
lowing terms associated to apolipoprotein or to the 8
lipid classes: sterol (cholesterol), prenol, fatty acid, acyl-
glycerol (triglyceride), phosphoglyceride, glycolipids,
polyketides and sphingolipids.
Syntenic conservation between the chicken and the
species where the lncRNA was discovered
The syntenic conservation analysis was performed for all
60 lncRNA genes identified in the first step, using the
following annotation reference databases: Ensembl v.92,
NCBI release 109, NONCODEv5 [18], ALDB v1.0 [119],
completed by the new lncRNA models that we have pre-
viously published for chicken [20, 28]. Long noncoding
gene conservation by synteny analysis between human/
mouse and chicken was performed according to three
criteria used in the following order of priority: 1. the
lncRNA in human/mouse genome is surrounded by two
neighboring protein-coding genes for which a 1-to-1
orthologous gene is available in the chicken genome. We
considered the lncRNA as syntenically conserved if this
lncRNA was also found in chicken between these two
orthologous protein-coding genes, in the same orienta-
tion and order and same relative position and/or intron-
exon structure. 2. The lncRNA in human/mouse gen-
ome is a close divergent lncRNA (< 1 kb) or antisense
from a protein-coding gene with a 1-to-1 orthologous
gene in the chicken genome; 3. the lncRNA in human/
mouse genome is hosting small noncoding genes. Such a
lncRNA was syntenically conserved if a lncRNA in
chicken is hosting small noncoding genes with the same
numbered-names.
Syntenic conservation between eight species
The syntenic conservation analysis was further per-
formed across eight species (human, mouse, goat, cattle,
pig, chicken, xenope and zebrafish) for the subset of 5
lncRNA genes, which were found conserved between the
chicken and the human/mouse. We used the same three
criteria aforementioned, taking the lncRNA reference
databases in the following order: Ensembl v.92, NCBI
annotation release 109, and the new lncRNA catalogue
that we have previously published for livestock species
(goat, cattle, pig) [28]. The phylogenetic tree was per-
formed with the phyloT v2018.3 tool (https://phylot.bio-
byte.de/), which generates phylogenetic trees based on
NCBI species names and taxonomy. The tree
visualization was carried out with the iTOL v4.2.3 tool
[120].
Tissue expression analysis in chicken and human
The human expression raw data from liver, white adi-
pose tissue and brain were obtained from RNAseq data
(2 × 100 bp) from three subjects (approximatively 18M
read-pairs per sample) chosen from the NCBI BioProject
accession number PRJEB4337 [110]. The aim of Fager-
berg et al. was to study tissue-specific expression of
genes from 27 healthy human tissues. The chicken liver
and abdominal adipose tissue expression data were ob-
tained from RNAseq data (2 × 100 bp) from 16 animals
(about 55M read-pairs per sample for liver and 70M for
adipose tissue) extracted from our PRJNA330615 project
[20]. The aim of Muret et al. was to model new lncRNA
in chicken in these two tissues. For the hypothalamus
and the embryo in chicken, the raw data used corres-
pond to RNAseq data (2 × 150 bp) from 16 individuals
(approximately 50M read-pairs per sample -
PRJEB28745). For these 2 species and all the tissues
mentioned, normalized RPKM data were used.
RT-PCR for remodeling gene structure
Total RNAs was extracted from the liver of 48 chickens
(from 9-weeks broilers) and mice (C57BL/6) as de-
scribed by Desert et al. [4] and reverse-transcribed using
High-Capacity cDNA Reverse Transcription kit (Applied
Biosystems, Foster City, CA) following manufacturer’s
instructions. cDNAs was treated with DNAseI (kit
Ambion – RNAse-free) and diluted 1:10 for specific
PCR amplification using the primers defined in Add-
itional file 2. The amplification specificity was confirmed
by sequencing. The amplification fragment lengths were
verified on 2% agarose gel using the marker SmartLad-
der (Eurogentec MW1700_10).
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s12864-019-6093-3.
Additional file 1: Gene structure of HMGCR. In blue: HMGCR isoforms
from Ensembl. In green: lncRNA AT102202 with 3 exons in common with
HMGCR isoforms. In purple: position of the siRNA used by Liu et al. for
the AT10202 knockdown and in red, primers used for the expression
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evaluation. Empty blocks represent noncoding regions. HMGCR isoforms
that encode the HMGCR protein are the first 3 models.
Additional file 2: List of primers used for model validation by RT-PCR.
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